Contact Us
|
Client Login
PRODUCTS & SERVICES
Antibody Products
Antibody Products Store
Neuroscience
Epitope Tags
Structural Proteins & Cell Components
Signal Transduction
Immunopathology
Detection Chemistries & Ancillaries
Custom Immunology Services
Clinical Services
Bioanalytical
Central Laboratory
Clinical Development (Phase I-III)
Discovery & Translational Services
Antibody Products
Biomarker Center of Excellence
BioPathways
Computational Biology
Discovery
Genomics Laboratory
Immunology
Vaccines & Infectious Disease
Nonclinical Services
Antibody Products
Bioanalytical Services
Discovery
Drug Metabolism & Pharmacokinetics
Immunology
Radiosynthesis
Research Models
Safety Pharmacology
Toxicology
Vaccines & Infectious Disease
Biopharmaceutical CMC Solutions
Biorepository Services
Environmental Sciences
Genomics Laboratory
Integration in Drug Development
Market Access
Nutritional Chemistry & Food Safety
Secure Data Access
Strategic Partnering
CAREERS
Search Jobs
College / University
Featured Jobs
Diversity
Benefits
现在就加入科文斯
STUDY PARTICIPANTS
INVESTORS
Investor Information
Investor Home
Stock Information
Board of Directors
Corporate Governance Guidelines
Analyst Coverage
Investor FAQ
Presentations & Webcasts
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
NEWS
Press Releases
Media Relations
ABOUT COVANCE
Company Overview
Global Locations
Corporate Responsibility
Business Integrity Program
Animal Welfare
Covance.Asia
RESOURCE CENTER
Blog
Investors
Investor Information
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
Home
> Investors >
Financial Information
>
Press Releases
Financial Information
Press Releases
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
Date
Title
29-Nov-2006
Covance Licenses Proprietary Innovative Clinical Solution from Oxford BioSignals Medical Providing More Efficient Cardiac Safety Assessment
Print
15-Nov-2006
Covance Expands Microdosing Capabilities; AMS Technology Cuts Time, Money From Drug Development
Print
09-Nov-2006
Covance Relocates Research Facility In Honolulu
Print
06-Nov-2006
Covance Expands Service and Investment in Drug Metabolism Industry, Charting Expansion with New Hires
Print
06-Nov-2006
Covance Adds Orbitrap(TM) to ADME Capabilities
Print
25-Oct-2006
Covance Reports Record Revenue and Earnings
Print
23-Oct-2006
Covance Continues North American Expansion of Bioanalytical Services
Print
26-Sep-2006
Covance Epidemiologist Appointments Further Strengthen Risk Management and Periapproval Services to Biopharmaceutical Companies
Print
22-Sep-2006
Covance Expands Research Clinic In Daytona Beach
Print
24-Jul-2006
Covance Reports Earnings Growth of 30% to $0.54/Share and Increases FY2006 Earnings Target to at Least $2.19/Share
Print
14-Jun-2006
Covance Announces $187 Million Dedicated Space Agreement
Print
31-May-2006
Covance Completes the Acquisition of the Phase I/IIA Business of Radiant Research Inc.
Print
31-May-2006
Covance Expands Its Antibody Products and Services With the Acquisition of Signet Laboratories
Print
01-May-2006
Covance Strengthens Clinical Trial Laboratory Services in Asia Pacific
Print
26-Apr-2006
Covance Reports Earnings Growth of 30% to $0.52 Per Share
Print
20-Apr-2006
Covance to Increase Phase I/IIa Capacity With Acquisition of Eight Early Clinical Development Sites From Radiant Research
Print
10-Apr-2006
Covance Introduces IVRS Express Services for Patient Enrollment, Randomization and Drug Supply Management
Print
07-Apr-2006
Covance Celebrates 10th Anniversary Milestone in Singapore
Print
06-Feb-2006
Deborah Tanner Will Be Promoted to President of Covance Central Laboratory Services
Print
25-Jan-2006
Covance Announces Record Results & Raises 2006 EPS Target
Print
23-Jan-2006
Covance Extends Presence in Central and Eastern Europe
Print
Home
|
Animal Welfare
|
Privacy Policy
|
Contact Us
|
Site Map
|
Investigators
|
Covance.Asia
RSS
© Copyright 2013 Covance Inc. All rights reserved.